Camber Pharmaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Camber Pharmaceuticals, Inc.

Sort by

Viewing results 1‒25 of 5484

WPP PLC
Ogilvy forms health influencer unit to target ‘new frontier’ in marketing
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
April 23, 2024
Covid-19 vaccines
EU delays approval of Novavax’s revised Covid jab
US biotech has been struggling to overcome fall in demand for coronavirus jabs
October 15, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthCovid-19 vaccines
Covid vaccine makers to clash in London over mRNA patent dispute
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
April 22, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
April 9, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
April 22, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
US healthcare company is putting cash to work from spinning off its consumer health arm
April 5, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Covid-19 vaccines
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
April 15, 2024
Corporate bonds
Reading small print for fun and profit
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
March 7, 2024
Behind the Money podcast17 min listen
Can WeightWatchers survive the Wegovy era?
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
April 10, 2024
Mergers & Acquisitions
EU wrong to block Illumina’s $8bn takeover of Grail, says court adviser
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
March 21, 2024
BlackRock Inc
BlackRock steps up security for Larry Fink after ‘anti-woke’ backlash
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
April 21, 2024
Medical science
UK approves Crispr gene editing therapy in global first
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
November 16, 2023
Pfizer Inc
Pfizer shares tumble on weak forecast for 2024 revenues
US drugmaker is trying to chart its future without blockbuster Covid-19 products
December 13, 2023
LexPfizer Inc
Pfizer: pharma group needs weight loss drug to secure post-Covid future Premium content
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
December 13, 2023
Coronavirus treatment
Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows
Millions of Paxlovid pills have gone unused as tight controls restrict access
January 1, 2024
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Pfizer Inc
Pfizer drops plan for twice-daily obesity pill due to side effects
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
December 1, 2023
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
October 9, 2023
Anjli Raval
Competent jerks have a shelf life in the office
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
January 14, 2024
LexFood & Beverage
Pepsi/obesity drugs: snack pack will withstand economies of scales Premium content
Investor worries about the impact of weight loss drugs on food companies are overdone
October 10, 2023
Drugs research
Roche agrees $7.1bn deal for Telavant to boost drug pipeline
...Teresa Graham, chief of Roche’s pharmaceutical division, said more patients suffered from diseases of the immune system than from cancer, and the current drugs did not serve them well....
October 23, 2023
Illumina Inc
EU regulators to order Illumina to sell $8bn cancer treatment group
Rare step comes after Brussels fined US biotech for buying Grail without approval
October 9, 2023
LexBoots UK Ltd
Boots: one step closer to the block Premium content
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
November 24, 2023
BioNTech
BioNTech writes down €900mn on Covid-19 vaccines
Biotech group hit by lower demand, with majority of write-offs relating to raw materials bought during pandemic
October 16, 2023
Illumina Inc
Illumina appoints new CEO after battle with investors
Biotech has been criticised for closing its $8bn acquisition of cancer test company Grail without regulatory approval
September 5, 2023
News in-depthPfizer Inc
Covid vaccine winners suffer reversal of fortune
Companies have yet to provide investors with convincing post-pandemic strategies
October 3, 2023

Previous pagePage 1 of 220Next page